Alphabet

The Alphabet subsidiary aced a long-running research competition with its deep-learning system, called AlphaFold.

Now available in public preview, the offerings are designed to help organizations and individuals pull clinically-relevant insights from large volumes of free text housed in medical records.

The company is releasing its research on mapping biomarkers for depression. 

Following news that its Project Baseline program was poorly received in parts of the Bay Area, the life science company characterized site closures as more of a pause and a redirection of resources across the state.

Dubbed Coefficient Insurance Company, it will combine Verily and Swiss Re Corporate Solutions' technology. 

Also: Dexcom continues to make strides, while iRhythm Technologies takes a hit in Q2. 

The regulator said it was not satisfied with Google's offer to silo Fitbit-collected data so that it could not be used for advertising purposes.

This comes a year after its last $63 million funding round. 

Alphabet, General Catalyst, Kholsa Ventures, Lakestar, Thrive Capital and Baillie Gifford participated in this round. 

Also: Wearables, AI support COVID-19 hydroxychloroquine study; Verizon Media deploys new COVID-19 dataset, API and dashboard.